Setting

APAC Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248391 | Pages: 192

Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 92 tables and 68 figures, this 192-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country. Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. Synthetic API • Branded Synthetic API • Generic Synthetic API Biotech API by Drug Type: • Monoclonal Antibodies • Recombinant Proteins • Vaccines • Other Biotech APIs Biotech API by Customer Base: • Innovative Biologic API • Generic Biosimilar API Biotech API by Expression Technology: • Mammalian Expression • Microbial Expression • Yeast Expression • Insect Expression • Other Expression Technologies HPAPI • Branded HPAPI • Generic HPAPI Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. Captive Manufacturing • Branded Captive API • Generic Captive API Merchant Manufacturing by Drug Type: • Branded Merchant API • Generic Merchant API Merchant Manufacturing by Drug Synthesis: • Merchant Synthetic API • Merchant Biotech API By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. • Infectious Diseases • Oncology • Ophthalmology • Cardiovascular Disorders • Central Nervous System • Pulmonary Disorders • Orthopedics • Other Applications By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. • Branded Prescription Drugs • Generic Prescription Drugs • OTC Drugs Geographically, the following national/local markets are fully investigated:UK • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: AbbVie Inc. Astrazeneca Aurobindo Pharma Ltd. BASF Bayer AG Boehringer Ingelheim Catalent Inc. Dr. Reddy's Laboratories F. Hoffmann-La Roche GlaxoSmithKline plc Lonza Group Lupin Limited Merck & Co., Inc. Mylan NV Novartis International AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 22 2.1.2 Impact of COVID-19 on the Market 24 2.2 Major Growth Drivers 31 2.3 Market Restraints and Challenges 39 2.4 Emerging Opportunities and Market Trends 42 2.5 Porter’s Fiver Forces Analysis 46 3 Segmentation of Asia Pacific Market by Synthesis 50 3.1 Market Overview by Synthesis 50 3.2 Synthetic API 52 3.2.1 Branded Synthetic API 53 3.2.2 Generic Synthetic API 54 3.3 Biotech API 55 3.3.1 Biotech API by Drug Type 56 3.3.1.1 Monoclonal Antibodies 57 3.3.1.2 Recombinant Proteins 58 3.3.1.3 Vaccines 59 3.3.1.4 Other Biotech APIs 60 3.3.2 Biotech API by Category 61 3.3.2.1 Innovative Biologic API 62 3.3.2.2 Generic Biosimilar API 63 3.3.3 Biotech API by Expression Technology 64 3.3.3.1 Mammalian Expression 65 3.3.3.2 Microbial Expression 66 3.3.3.3 Yeast Expression 67 3.3.3.4 Insect Expression 68 3.3.3.5 Other Expression Technologies 69 3.4 HPAPI 70 3.4.1 Branded HPAPI 71 3.4.2 Generic HPAPI 72 4 Segmentation of Asia Pacific Market by Manufacturing Process 73 4.1 Market Overview by Manufacturing Process 73 4.2 Captive Manufacturing 75 4.2.1 Branded Captive API 76 4.2.2 Generic Captive API 77 4.3 Merchant Manufacturing 78 4.3.1 Merchant Manufacturing by Drug Type 79 4.3.1.1 Branded Merchant API 80 4.3.1.2 Generic Merchant API 81 4.3.2 Merchant Manufacturing by Drug Synthesis 82 4.3.2.1 Merchant Synthetic API 83 4.3.2.2 Merchant Biotech API 84 5 Segmentation of Asia Pacific Market by Therapeutic Application 85 5.1 Market Overview by Therapeutic Application 85 5.2 Infectious Diseases 87 5.3 Oncology 88 5.4 Ophthalmology 89 5.5 Cardiovascular Disorders 90 5.6 Central Nervous System 91 5.7 Pulmonary Disorders 92 5.8 Orthopedics 93 5.9 Other Applications 94 6 Segmentation of Asia Pacific Market by Drug Type 95 6.1 Market Overview by Drug Type 95 6.2 Branded Prescription Drugs 97 6.3 Generic Prescription Drugs 98 6.4 OTC Drugs 99 7 Asia-Pacific Market 2021-2028 by Country 100 7.1 Overview of Asia-Pacific Market 100 7.2 China 103 7.3 Japan 105 7.4 India 108 7.5 Australia 110 7.6 South Korea 112 7.7 Rest of APAC Region 114 8 Competitive Landscape 116 8.1 Overview of Key Vendors 116 8.2 New Product Launch, Partnership, Investment, and M&A 119 8.3 Company Profiles 120 AbbVie Inc. 120 Astrazeneca 122 Aurobindo Pharma Ltd. 127 BASF 130 Bayer AG 133 Boehringer Ingelheim 137 Catalent Inc. 142 Dr. Reddy's Laboratories 145 F. Hoffmann-La Roche 147 GlaxoSmithKline plc 149 Lonza Group 154 Lupin Limited 159 Merck & Co., Inc. 162 Mylan NV 165 Novartis International AG 168 Pfizer Inc. 171 Sanofi 176 Sun Pharmaceutical Industries Ltd. 179 Teva Pharmaceutical Industries Ltd. 182 Thermo Fisher Scientific 184 9 Investing in Asia Pacific Market: Risk Assessment and Management 186 9.1 Risk Evaluation of Asia Pacific Market 186 9.2 Critical Success Factors (CSFs) 189 Related Reports and Products 192
List Of Tables:
Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19 Table 2. World Economic Outlook, 2021-2031 23 Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 38 Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market 42 Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 50 Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn 52 Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn 56 Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn 61 Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn 64 Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn 70 Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 73 Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn 75 Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn 79 Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn 82 Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 85 Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn 95 Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn 101 Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 104 Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 104 Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 104 Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 107 Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 107 Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 107 Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 109 Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 109 Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 109 Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 111 Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 111 Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 111 Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 113 Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 113 Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 113 Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, $ bn 115 Table 34. AbbVie Inc.: Company Snapshot 120 Table 35. AbbVie Inc.: Product Portfolio 120 Table 36. AbbVie Inc.: Revenue, 2018-2020, $ bn 121 Table 37. Astrazeneca: Company Snapshot 122 Table 38. Astrazeneca: Revenue, 2018-2020, $ bn 123 Table 39. Aurobindo Pharma Ltd.: Company Snapshot 127 Table 40. Aurobindo Pharma Ltd.: Product Portfolio 128 Table 41. BASF: Company Snapshot 130 Table 42. BASF: Business Segmentation 131 Table 43. BASF: Revenue by Region 131 Table 44. Bayer AG: Company Snapshot 133 Table 45. Bayer AG: Business Segmentation 134 Table 46. Bayer AG: Revenue, 2018-2020, € bn 134 Table 47. Boehringer Ingelheim: Company Snapshot 137 Table 48. Boehringer Ingelheim: Business Segmentation in 2019 138 Table 49. Boehringer Ingelheim: Product Portfolio 138 Table 50. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 139 Table 51. Boehringer Ingelheim: Revenue by Region in 2019 139 Table 52. Catalent Inc.: Company Snapshot 142 Table 53. Catalent Inc.: Business Segmentation in 2018 143 Table 54. Catalent Inc.: Product Portfolio 143 Table 55. Catalent Inc.: Revenue, 2018-2020, $ million 144 Table 56. Catalent Inc.: Revenue by Region in 2018 144 Table 57. Dr. Reddy's Laboratories: Company Snapshot 145 Table 58. Dr. Reddy's Laboratories: Business Segmentation 145 Table 59. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn 146 Table 60. F. Hoffmann-La Roche: Company Snapshot 147 Table 61. F. Hoffmann-La Roche: Business Segmentation 148 Table 62. GlaxoSmithKline: Company Snapshot 149 Table 63. GlaxoSmithKline: Business Segmentation 150 Table 64. GlaxoSmithKline: Product Portfolio 151 Table 65. GlaxoSmithKline: Revenue, 2018-2020, $ bn 152 Table 66. Lonza Group: Company Snapshot 154 Table 67. Lonza Group: Business Segmentation in 2018 155 Table 68. Lonza Group: Product Portfolio 155 Table 69. Lonza Group: Revenue by Region in 2018 156 Table 70. Lupin Limited: Company Snapshot 159 Table 71. Lupin Limited: Business Segmentation 159 Table 72. Merck & Co., Inc.: Company Snapshot 162 Table 73. Merck & Co., Inc.: Business Segmentation 162 Table 74. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 163 Table 75. Mylan NV: Company Snapshot 165 Table 76. Mylan NV: Revenue, 2017-2019, $ bn 166 Table 77. Novartis International AG: Company Snapshot 168 Table 78. Novartis International AG: Business Segmentation 168 Table 79. Novartis International AG: Revenue, 2017-2019, $ bn 169 Table 80. Pfizer Inc.: Company Snapshot 171 Table 81. Pfizer Inc.: Business Segmentation 172 Table 82. Pfizer Inc.: Product Portfolio 173 Table 83. Pfizer Inc.: Revenue, 2018-2020, $ bn 173 Table 84. Sanofi: Company Snapshot 176 Table 85. Sanofi: Business Segmentation 176 Table 86. Sanofi: Revenue, 2018-2020, $ bn 177 Table 87. Sun Pharmaceutical Industries Limited: Company Snapshot 179 Table 88. Teva Pharmaceutical Industries Ltd.: Company Snapshot 182 Table 89. Teva Pharmaceutical Industries Ltd.: Business Segmentation 183 Table 90. Thermo Fisher Scientific: Company Snapshot 184 Table 91. Risk Evaluation for Investing in Asia Pacific Market, 2021-2028 187 Table 92. Critical Success Factors and Key Takeaways 190
List Of Figures:
Figure 1. Research Method Flow Chart 13 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16 Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028 18 Figure 4. Asia Pacific Active Pharmaceutical Ingredients (API) Market, 2021-2028, $ bn 21 Figure 5. Impact of COVID-19 on Business 24 Figure 6. Primary Drivers and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market 31 Figure 7. GDP per capita in the World, 1960-2018, $ thousand 34 Figure 8. Leading Causes of Death in the World, 2019-2020, million 35 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36 Figure 11. Primary Restraints and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market 39 Figure 12. Investment Opportunity Analysis 43 Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Active Pharmaceutical Ingredients (API) Market 46 Figure 14. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue 50 Figure 15. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 51 Figure 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, $ bn 52 Figure 17. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, $ bn 53 Figure 18. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, $ bn 54 Figure 19. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, $ bn 55 Figure 20. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, $ bn 57 Figure 21. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, $ bn 58 Figure 22. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, $ bn 59 Figure 23. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, $ bn 60 Figure 24. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, $ bn 62 Figure 25. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, $ bn 63 Figure 26. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, $ bn 65 Figure 27. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, $ bn 66 Figure 28. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, $ bn 67 Figure 29. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, $ bn 68 Figure 30. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, $ bn 69 Figure 31. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, $ bn 70 Figure 32. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, $ bn 71 Figure 33. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, $ bn 72 Figure 34. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue 73 Figure 35. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 74 Figure 36. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, $ bn 75 Figure 37. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, $ bn 76 Figure 38. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, $ bn 77 Figure 39. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, $ bn 78 Figure 40. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, $ bn 80 Figure 41. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, $ bn 81 Figure 42. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, $ bn 83 Figure 43. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, $ bn 84 Figure 44. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue 85 Figure 45. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 86 Figure 46. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, $ bn 87 Figure 47. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, $ bn 88 Figure 48. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, $ bn 89 Figure 49. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, $ bn 90 Figure 50. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, $ bn 91 Figure 51. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, $ bn 92 Figure 52. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, $ bn 93 Figure 53. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, $ bn 94 Figure 54. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue 95 Figure 55. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 96 Figure 56. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, $ bn 97 Figure 57. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, $ bn 98 Figure 58. Asia Pacific Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, $ bn 99 Figure 59. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue 101 Figure 60. Contribution to APAC 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%) 102 Figure 61. Active Pharmaceutical Ingredients (API) Market in China, 2018-2028, $ bn 103 Figure 62. Active Pharmaceutical Ingredients (API) Market in Japan, 2018-2028, $ bn 106 Figure 63. Active Pharmaceutical Ingredients (API) Market in India, 2018-2028, $ bn 108 Figure 64. Active Pharmaceutical Ingredients (API) Market in Australia, 2018-2028, $ bn 110 Figure 65. Active Pharmaceutical Ingredients (API) Market in South Korea, 2018-2028, $ bn 112 Figure 66. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2018-2028, $ bn 114 Figure 67. Growth Stage of Asia Pacific Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 116 Figure 68. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars) 123
Selected Key Players: 
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)